Massachusetts 2023-2024 Regular Session

Massachusetts House Bill H1148

Introduced
2/16/23  
Refer
2/16/23  

Caption

Relative to prescription drug pricing

Impact

If enacted, HB 1148 would significantly influence state laws governing healthcare and insurance practices in Massachusetts. The legislation mandates that PBMs must secure a license from the state’s insurance commissioner, who will also establish detailed procedures and regulations for PBM operations. This change not only aims to standardize practices across the board but also addresses instances of potential misrepresentation and unfair dealings within the pharmacy benefits market. Ultimately, the bill holds the potential to provide better cost control measures, enhancing the affordability of prescription medications for consumers.

Summary

House Bill 1148, titled 'An Act relative to prescription drug pricing,' introduces regulatory measures to enhance the oversight of pharmacy benefits managers (PBMs) in Massachusetts. The bill aims to establish a licensing requirement for PBMs, ensuring that these entities adhere to specific operational standards when managing prescription drug benefits. This includes mandates for transparency in pricing and reimbursement processes, which seeks to empower both providers and consumers through increased access to pricing information and appeals against unfair reimbursement practices. The bill's framework is intended to create a more equitable and transparent system in the pharmaceutical landscape of the state.

Contention

Debates surrounding HB 1148 may center around the balance of regulatory control and the operational flexibility of PBMs. Some stakeholders advocate for stringent regulations, arguing that greater oversight is necessary to curb excessive pricing practices and improve patient access to medications. Conversely, there are concerns among PBMs and certain industry representatives regarding the added regulatory burden, which they fear could lead to increased operational costs that may ultimately be passed down to consumers. Additionally, discussions may arise concerning the appropriateness of the proposed licensing fees, which could impact smaller PBMs and their ability to operate effectively within the state.

Companion Bills

MA H1201

Similar To To promote transparency in prescription drug prices

MA H4879

Replaced by Study Order

Similar Bills

WV HB4112

Provide consumers a choice for pharmacy services

MS HB1125

Pharmacy services; prohibit insurers and PBMs from requiring persons to obtain exclusively through pharmacies that they own.

NH HB1580

Relative to pharmacy benefits managers.

SD HB1135

Provide for transparency in the pricing of prescription drugs.

AL SB252

Pharmacy Benefits Managers; providing a prescription reimbursement rate for independent pharmacies and regulating other practices

AL SB93

Pharmacy Benefits Managers; providing additional regulation of practices

WV SB557

Providing that pharmacy may decline to dispense prescription drug where reimbursement is less than pharmacy's cost

AL SB99

Drug Insurance Benefits; impose more restrictions on pharmacy benefit managers